Rewriting Cellular Instructions to Make Better Tumor-Fighting Immunotherapies
Rewriting Cellular Instructions to Make Better Tumor-Fighting Immunotherapies
A powerful scientific platform opens new possibilities for treating cancer, autoimmune diseases, and other conditions in which reprogrammed T cells could provide a benefit to patients.
News Release Research (Publication) Cancer Genomic Immunology Marson Lab CRISPR/Gene Editing


